ReviewNeurology and therapy2020

CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer's Disease-A Narrative Review.

Nirmal Chandra Barman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.